Healthcare partnerships Fleming Medical has a track record of collaborating with major health institutions and organizations such as RCSI, NUIG, The Tyndall Institute, Irish Heart Foundation, Allergy Ireland, Munster Rugby, and the RCSI Hospital Group, presenting ongoing opportunities to expand co-developed medical devices, diagnostics, and educational initiatives with healthcare networks.

Chronic care focus The company emphasizes wearable technology for chronic conditions and smart wound care through Dermatrax, indicating a strong market interest in advanced monitoring solutions and value-based care products that can command higher margins and multi-year adoption.

Wound care innovation Dermatrax positions Fleming Medical at the frontier of sensor-enabled wound dressings with app-based viability assessments, suggesting a potential upsell of sensors, data platforms, and integration with pharmacy or hospital IT systems.

Pharmacy accessibility Recent initiative with Irish Heart Foundation to offer free blood pressure checks in pharmacies demonstrates a channel and data collection opportunity for point-of-care devices, telehealth integration, and cross-sell of diagnostic consumables to retail pharmacy partners.

Growth through education Ongoing collaborations with Allergy Ireland, medical education content, and sponsor partnerships indicate a pathway to license or co-create training kits, educational programs, and clinician-facing solutions that can expand product adoption and frontline usage.